Sanjay Awasthi
Overview
Explore the profile of Sanjay Awasthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
3464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Philipovskiy A, Ghafouri R, Dwivedi A, Alvarado L, McCallum R, Maegawa F, et al.
Front Oncol
. 2022 Feb;
11:772225.
PMID: 35141142
In the United States, CRC is the third most common type of cancer and the second leading cause of cancer-related death. Although the incidence of CRC among the Hispanic population...
12.
Bose C, Hindle A, Lee J, Kopel J, Tonk S, Palade P, et al.
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944997
Her2-amplified breast cancers resistant to available Her2-targeted therapeutics continue to be a challenge in breast cancer therapy. Dox is the mainstay of chemotherapy of all types of breast cancer, but...
13.
Awasthi S, Hindle A, Sawant N, George M, Vijayan M, Kshirsagar S, et al.
Cells
. 2021 Nov;
10(11).
PMID: 34831336
The purpose of our study is to understand the role of the gene in oxidative stress (OS), mitochondrial dysfunction and cognition in Alzheimer's disease (AD) pathogenesis. The gene encodes the...
14.
Singh S, Lee J, Bose C, Li H, Yuan Y, Hindle A, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34283045
We recently reported that loss of one or both alleles of , which encodes the stress-protective protein RLIP76 (Rlip), exerts a strong dominant negative effect on both the inherent cancer...
15.
Petkovic M, Leal E, Alves I, Bose C, Palade P, Singh P, et al.
J Nutr Biochem
. 2021 Jul;
98:108817.
PMID: 34271100
Visible impairments in skin appearance, as well as a subtle decline in its functionality at the molecular level, are hallmarks of skin aging. Activation of the nuclear factor (erythroid-derived 2)-like...
16.
Singhal S, Srivastava S, Mirzapoiazova T, Horne D, Awasthi S, Salgia R
Cancer Lett
. 2021 Jun;
518:10-22.
PMID: 34126193
The treatment of metastatic melanoma is greatly hampered by the simultaneous dysregulation of several major signaling pathways that suppress apoptosis and promote its growth and invasion. The global resistance of...
17.
Singhal S, Mohanty A, Kulkarni P, Horne D, Awasthi S, Salgia R
Carcinogenesis
. 2021 Feb;
42(5):742-752.
PMID: 33623991
The incidence of malignant melanoma, a neoplasm of melanocytic cells, is increasing rapidly. The lymph nodes are often the first site of metastasis and can herald systemic dissemination, which is...
18.
Singhal J, Kulkarni P, Horne D, Awasthi S, Salgia R, Singhal S
Mol Carcinog
. 2021 Feb;
60(3):213-223.
PMID: 33544936
The overexpression and amplification of the protooncogene neu (ERBB2) play an important role in the development of aggressive breast cancer (BC) in humans. Ral-interacting protein (RLIP), a modular stress-response protein...
19.
Singhal S, Horne D, Singhal J, Awasthi S, Salgia R
Biochim Biophys Acta Rev Cancer
. 2021 Jan;
1875(2):188512.
PMID: 33460725
Aberrations in RLIP, p53, and PKCα represent essentially the entire spectrum of all human neoplasms. Elevated PKCα expression, failure of the cell cycle checkpoint (p53 dysfunction), and abnormal glutathione (GSH)...
20.
Awasthi S
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33445456
Mutagenic environmental chemical or radiant stresses directly damage DNA and amplify the formation of potent endogenous mutagens from lipid peroxidation, leading to cancers that cause millions of deaths and impose...